Study of EV for Recurrent Endometrial Carcinoma
NCT07139977
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Endometrial Cancer
Interventions
DRUG:
Enfortumab Vedotin
Sponsor
William Bradley
Collaborators
[object Object]